Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057312 · ClinicalTrials.gov registry record · NA
Promoting HPV Vaccination Among Young Adults in Texas
A NA study of Human Papillomavirus Infection, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 1
- Study location
NCT05057312: Active NA study of Human Papillomavirus Infection, sponsored by M.D. Anderson Cancer Center.
NCT05057312 is a NA study of Human Papillomavirus Infection that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,200 participants, roughly in line with the 1,224-participant average among 22 other Human Papillomavirus Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05057312, a NA study of Human Papillomavirus Infection, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.
Conditions Studied
Interventions
- OTHER Interview
- OTHER Informational Intervention
- OTHER Enhancing Accessibility to Health Care
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT05057312 still lists
NCT05057312 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,224-participant average among 22 other Human Papillomavirus Infection trials with a reported enrollment target.
The record links to 1 condition, with Human Papillomavirus Infection appearing as the primary indexed condition, and to 3 interventions - of which Interview is the first listed.
NCT05057312 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05057312 about?
NCT05057312 is a clinical study titled "Promoting HPV Vaccination Among Young Adults in Texas". This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.
What is the current status of trial NCT05057312?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2021-07-26. Estimated completion is 2026-07-31.
What conditions does trial NCT05057312 study?
This clinical trial studies the following conditions: Human Papillomavirus Infection.
What interventions are being tested in trial NCT05057312?
The interventions under investigation include: Interview (OTHER), Informational Intervention (OTHER), Enhancing Accessibility to Health Care (OTHER).
Who is sponsoring clinical trial NCT05057312?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05057312 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05057312's enrollment target sits among peer trials
1,200 5th of 22 higher than 18 of 22 other Human Papillomavirus Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papillomavirus Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI